Namba Tomoko, Yamamoto Takeshi, Matsuda Jun, Kadoya Hiroyuki, Takeji Masanobu, Yamauchi Atsushi
Division of Nephrology, Osaka Rosai Hospital, Osaka, Japan.
Nihon Jinzo Gakkai Shi. 2010;52(1):66-72.
Henoch-Schönlein purpura (HSP) is a systemic disorder characterized by small vessel vasculitis with the deposition of IgA immune complexes. Renal involvement is the major cause of morbidity and mortality in patients with HSP. We report here a 37-year-old female patient with HSP nephritis (HSPN) associated with steroid-resistant nephrotic syndrome and renal dysfunction despite conventional therapy. The patient was successfully treated with intravenous cyclophosphamide following treatment with intravenous pulse methylprednisolone and oral prednisolone. The combination therapy resulted in a significant decrease in proteinuria, together with improvement of renal function. The patient finally reached a stage of clinical remission.
过敏性紫癜(HSP)是一种以小血管血管炎伴IgA免疫复合物沉积为特征的全身性疾病。肾脏受累是HSP患者发病和死亡的主要原因。我们在此报告一名37岁的女性过敏性紫癜肾炎(HSPN)患者,尽管接受了常规治疗,但仍伴有激素抵抗性肾病综合征和肾功能不全。该患者在接受静脉注射脉冲甲基强的松龙和口服强的松龙治疗后,成功接受了静脉注射环磷酰胺治疗。联合治疗使蛋白尿显著减少,同时肾功能得到改善。患者最终达到临床缓解阶段。